RXRB and cancer: Through analyses of both clinical samples and TCGA database, we confirmed that RAB39A was expressed in sarcomas and malignancies of lymphoid, adrenal and testicular tissues; and RXRB abundance was constantly widespread in various cancers, suggesting that RXRB functions with the saturated level in cancers.